These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8237833)

  • 1. The CASCADE Study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. CASCADE Investigators.
    Greene HL
    Am J Cardiol; 1993 Nov; 72(16):70F-74F. PubMed ID: 8237833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
    Am J Cardiol; 1993 Aug; 72(3):280-7. PubMed ID: 8342505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study).
    Am J Cardiol; 1991 Mar; 67(7):578-84. PubMed ID: 2000790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G; Greene HL
    Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation.
    Dolack GL
    Am J Cardiol; 1994 Feb; 73(4):237-41. PubMed ID: 8296753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
    Anderson JL
    J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rehospitalization in surviving patients of out-of-hospital ventricular fibrillation (the CASCADE Study). Cardiac Arrest in Seattle: Conventional Amiodarone Drug Evaluation.
    Maynard C
    Am J Cardiol; 1993 Dec; 72(17):1295-300. PubMed ID: 8256707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
    Tsai CF; Chen SA; Tai CT; Chiang CE; Ding YA; Chang MS
    Int J Cardiol; 1998 Mar; 64(1):47-55. PubMed ID: 9579816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
    Kudenchuk PJ; Cobb LA; Copass MK; Cummins RO; Doherty AM; Fahrenbruch CE; Hallstrom AP; Murray WA; Olsufka M; Walsh T
    N Engl J Med; 1999 Sep; 341(12):871-8. PubMed ID: 10486418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
    Haverkamp W; Eckardt L; Borggrefe M; Breithardt G
    Am J Cardiol; 1997 Oct; 80(8A):67G-73G. PubMed ID: 9354413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
    Kudenchuk PJ; Brown SP; Daya M; Rea T; Nichol G; Morrison LJ; Leroux B; Vaillancourt C; Wittwer L; Callaway CW; Christenson J; Egan D; Ornato JP; Weisfeldt ML; Stiell IG; Idris AH; Aufderheide TP; Dunford JV; Colella MR; Vilke GM; Brienza AM; Desvigne-Nickens P; Gray PC; Gray R; Seals N; Straight R; Dorian P;
    N Engl J Med; 2016 May; 374(18):1711-22. PubMed ID: 27043165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
    Dorian P; Cass D; Schwartz B; Cooper R; Gelaznikas R; Barr A
    N Engl J Med; 2002 Mar; 346(12):884-90. PubMed ID: 11907287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT).
    Crystal E; Kahn S; Roberts R; Thorpe K; Gent M; Cairns JA; Dorian P; Connolly SJ
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):633-7. PubMed ID: 12658206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.